Running head: Primary Care Providers' Views on a Future Lung Cancer Screening Program Key words: early detection of cancer; family practice; qualitative research 3 Key Messages  Variable primary care provider preferences for role in lung cancer screening  Primary care providers want information about lung cancer screening  Allied health professionals may have role in assessing eligibility for screening  Smoking cessation is a key strategy in any lung cancer screening program Abstract Background: The National Lung Screening Trial demonstrated that screening with low dose computed tomography significantly reduces mortality from lung cancer in high risk individuals.
Recruitment of the RPCLs was by email from staff at Cancer Care Ontario, the cancer organization in the province. For the FHTs and CHCs, PCPs and staff including nurse practitioners, nurses, prevention and administrative staff were invited to participate by the site lead physician.
Data Collection: An interview guide was developed by two team members (DL, MAO) and reviewed with the team. Focus groups were used to explore attitudes toward LDCT screening. Within each focus group, a modified nominal group process (17) was used to identify and prioritize information needs of PCPs.
Before each focus group, participants were sent slides containing information on the current study and NLST findings (Table 1) . Focus groups were held between June and October 2014, were led by an experienced qualitative researcher (DL) and co-facilitated by other team members (FS and/or MAO).
Coding and Analysis: Two team members (DL, MAO) developed a coding scheme then applied it independently to each interview transcript. NVivo software (NVivo 9, QSR International) was used for data management. Meetings were held to resolve any disagreements. Overarching themes were derived from the coded data. The data were explored for confirming and disconfirming concepts using principles of the constant comparative method (18) . We reached informational saturation (19) . All analytic steps were documented in an audit trail (20) . In the design, we followed principles proposed by Malterud to ensure study rigor (21) including a systematic process for the analysis and examination of data for evidence of disconfirming views. We used the consolidated criteria for reporting qualitative research (22) in the preparation of the manuscript ( Supplemental Table S1 ).
Individual PCPs and teams were offered $200.00 CAD as an acknowledgement of the time required for study participation. The study was approved by the North York Hospital Research Ethics Board (REB) and the University of Toronto REB.
Results
Four in-person focus groups were held with 33 PCPs and staff: 27 (82%) female; 21 (64%) physicians, 6 (18%) allied health professionals (AHPs), 6 (18%) administrative staff. AHPs included nurse practitioners, nurses, and prevention counsellors ( Table 2 ).
Most PCPs had positive attitudes toward a potential LDCT screening service in Ontario. Physicians recounted difficult experiences with patients with Stage 4 lung cancer and hoped that screening would lead to increased early detection and treatment.
As one family physician said, "…this is something that I'm excited about being able to do. Anyone who has been in practice for a length of time has seen these patients…, you see the spot on the x-ray or they have a symptom and you know what's coming and it's devastating to you and your patient." PCP, CHC The detailed analysis resulted in five major themes; these are summarized below.
Themes

Variable preferences for involvement of PCPs in identifying eligible patients for LDCT screening
Several PCPs were supportive of some involvement in LDCT screening such as running searches on electronic medical records (EMRs) to identify eligible patients and by discussing pros and cons of LDCT screening with patients. These activities were similar to those undertaken by PCPs in other areas of cancer screening. As one PCP said, "… I think we could very well be involved because our EMRs, we target smokers and we can run searches on our EMRs to find patients, exactly the ones you're looking for, so... we do it for all the big four, colon cancer and so on." PCP Northern Ontario While only a few PCPs thought they could implement full eligibility screening, others said they could conduct a pre-assessment for patients. For example, "I can't speak for other doctors but I'd probably be doing it [pre-assessment] in the office myself if it was an easy sort of handout …. That way you could refer the person with the score and then it was either denied or approved based on that." PCP FHT However, other PCPs preferred a minimal role in screening such as advertising in waiting rooms. PCPs who preferred a minimal role were concerned about increased workload associated with screening. For example, "[In] 10 to 15 minutes I cannot see myself conscientiously committing to doing anything else … I like our
[EMR] reminders… of the PAPs, the mammograms, the faecal occult blood. This could certainly be something else that's there. But I cannot conscientiously say that I'm going to be able to do this." PCP
Northern Ontario
PCPs also noted that unlike other screening programs that are largely age-based, LDCT screening for lung cancer is based on other factors such as amount smoked and duration of smoking. PCPs expressed that there was potential for confusion about eligibility for screening based on age and smoking history alone especially since smoking history may not be well-documented in the EMR.
Other primary care practice professionals may have a role in LDCT screening
Allied Health Professionals (AHPs)
PCPs indicated that AHPs -such as Nurse Practitioners, Registered Nurses, and Registered Practical Nurses-could, in certain situations play an active role in identifying eligible patients and by providing information about LDCT screening. Physicians said that AHPs could conduct brief lung cancer risk assessments for new patients. Nurses in the FHT and CHC groups concurred and emphasized the importance of their training and experience that would enable them to conduct risk assessments. It was noted that AHP involvement in the identification of eligible patients might not be feasible in practices with few and/or busy AHPs.
For example, a PCP who supported the involvement of AHPs in LDCT screening said, "…for us it would be an RN [Registered Nurse] or a RNA [Registered Nursing Assistant] who's processing the patient, sees that the person's a smoker, has been for a long time, and that she would have more time.." PCP Northern Ontario AHPs raised another positive aspect of preliminary screening by nurses such as helping patients with low literacy. For example, "We have a lot of clientele that have barriers to learning so I don't want to get them agitated if we're asking them to do a survey and they can't read or even write... so maybe it's a good thing even if the nurses did a little bit of the survey with them..." AHP, CHC
Role of Front Desk Staff
PCPs did not think that it would not be appropriate for front desk staff to conduct the eligibility assessment of patients for LDCT screening and that staff would have a very limited role in supporting patients. Front desk staff indicated that staff training would be essential for them to understand all steps in a screening program so they could in turn, describe them to patients. Front desk staff emphasized their role in communicating with patients and the importance of taking a customer service approach so that patients would not be confused or misinformed about LDCT screening.
For example, a staff member said, "Even when we have to send people down to get an x-ray or to get a MRI they hear the names but they really don't know what they're going for. They don't really understand it. " Staff member, FHT Staff described that they were an important source of information and related several situations with other screening programs whereby patients expressed uncertainty about next steps and turned to staff for help.
PCPs and AHPs have high information needs about LDCT lung cancer screening
Across all four focus groups, PCPs and AHPs discussed their information needs about LDCT screening.
PCPs rated the following topics as high priority for information: evidence for LDCT screening including potential benefits and harms such as false positive results; program eligibility criteria including descriptions of those considered to be at high risk to develop lung cancer; suggestions for communicating risk information to patients; details of a proposed screening process; and the follow-up process for abnormal results. AHP and office staff wanted to know more about eligibility criteria and the screening process so they could provide accurate information to patients. Participants recommended that LDCT screening programs provide standardized information packages to PCPs for distribution to patients. For example, "Is this gonna come back to me and say well there's an abnormal CT chest with a two centimeter nodule, have a nice day, or is it recommend CT, three months to gauge interval, recommend biopsy immediately for suspicious lesion ? I mean how much is gonna be communicated to me to what happens when the CT doesn't come back normal?" PCP, FHT
PCPs recommend that a future LDCT screening service be modelled on the current Ontario Breast
Links to smoking cessation is crucial for PCPs to support a future program
PCPs strongly expressed that smoking cessation services should be a key component of a lung cancer screening program. PCPs were highly supportive of smoking cessation services while acknowledging that there were regional differences in service provision. PCPs perceived that a new LDCT screening program for lung cancer would provide an impetus for them to re-engage with patients who continued to smoke. "… this is a phenomenal opportunity for those people who are identified as not being eligible for the low dose CT to have a discussion regarding smoking cessation. That's absolutely crazy not to use this as an opportunity." PCP, RPCL RPCLs explained that the effective integration of smoking cessation services into the screening process would be a key feature that will increase the acceptability of LDCT lung cancer screening among Ontario family physicians.
Discussion
Our study examined PCPs' views of their potential roles in an organized LDCT program, identified significant knowledge needs and highlighted aspects of a program that are desired based on experiences with other screening programs. We found that most PCPs were generally supportive of an organized LDCT lung cancer screening program; however, there was considerable variability in PCPs' preferences for their role. An implication of this finding is that a future organized LDCT screening program in Ontario that relies on PCPs to identify potentially eligible patients, refer them for screening, and follow up on results may not be feasible. PCPs also expressed concerns about the identification of high-risk patients in the EMR especially those who had quit smoking within the last 15 years. Greiver et al. have reported that identifying smoking history from the EMR may be difficult (23) .
The current study contributes information about implementation of organized LDCT screening programs including the roles of PCPs and AHPs. As LDCT screening is being implemented outside of a trial setting, it is important to investigate the perspectives of key stakeholders including PCPs who will have some role in such a program. PCPs routinely screen patients for other types of cancers-breast, cervical, and colorectal. They have trusting relationships with patients and are well-placed to counsel them about the risks and benefits of screening. LDCT screening is known to have high false positive rates (6) and it is important that patients understand such risks and potential benefits before agreeing to participate in a LDCT screening program. There is emerging evidence that patient decision aids may be helpful to provide information about risks and benefits of LDCT screening (24, 25) although, participants in our study were unaware of such tools.
Several of our findings are similar to other research in primary care (9, (26) (27) (28) . For example, Hoffman et al. described the perspectives of PCPs from New Mexico, US. In their study, several PCPs were unaware of the NLST and its application to their setting. PCPs in that study also expressed concerns about the high false positive screening rate (9) . Kanodra and colleagues conducted a qualitative study of the views of patients (n=28) and PCPs (n = 13) at a Veterans Administration medical centre . While 58% of these providers were aware of US Preventive Services Task Force screening guidelines, few providers could describe eligibility criteria. Providers indicated that shortage of time was a significant factor in limiting their ability to counsel patients about LDCT screening. They preferred that a screening coordinator review any incidental findings with patients and need for ongoing screening (26) .
Our study found that PCPs preferred a specific model for a future organized LDCT screening program, in which the program arranged screening and follow up while communicating with PCPs, based on experience with an existing organized screening program for breast cancer patients that worked well for PCPs, their staff and patients.
Strengths and Limitations:
We conducted our study in several health regions in Ontario, Canada and sampled PCPs from different practice types including FHTs and community health centres, and included AHP and staff in our focus groups. This is important as our results show that AHPs may have a key supportive role in a screening program and referrals to smoking cessation programs.. The extent that our findings would be similar to those in other health regions or in different practice types is unknown.
Although we attempted to recruit physicians from a purely fee for service payment model, none of the volunteer participants were from this type of model and we do not know if our findings would apply to them.. We asked PCPs about their roles in a potential rather than actual LDCT program; however, PCPs had considerable experience with other types of organized screening programs.
Conclusions
A future Ontario LDCT lung cancer screening program should consider the variability in PCPs' preferred roles.
PCPs preferred that a future lung cancer screening program be modelled on the OBSP including follow up of positive findings,and have explicit links to smoking cessation programs.
A future program should provide information materials and learning opportunities tailored to PCPs' identified needs.
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